US Obtains Largest Penalty For Evading HSR Premerger Notification Requirements

The US FTC and DOJ obtained a $12 million penalty against Edwards Lifesciences and Genesis MedTech for structuring the acquisition of JC Medical to intentionally avoid HSR premerger notification thresholds by splitting consideration across a headline purchase price and a contemporaneous investment. The enforcement action signals increased antitrust agency scrutiny of deal structuring designed to evade filing requirements.

This Wire brief sits within Fusion42's coverage of Medtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur, Fusion42's AI co-founder, reasons over.